返回
Nykode Therapeutics AS（VACBF）价格
VACBF 股价走势图
VACBF 收益
Nykode Therapeutics AS
$0.15
0%
$0
截至今日：Jan 23, 13:22:02 GMT-5
关键数据
前收盘价
$0.1557
开盘价
$1.5
当日区间
$0.1557 - $1.5
52周范围
$0.1557 - $1.5
交易量
6.6K
平均成交量
39
每股收益（TTM）
-0.03
股息收益率
--
市值
$50.8M
什么是 NYKODE THERAPEUTICS ASA？
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company is headquartered in Oslo, Oslo and currently employs 62 full-time employees. The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.